Values First Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$360K Buy
2,203
+146
+7% +$22.4K 0.19% 123
2025
Q4
$358K Sell
2,057
-3,409
-62% -$622K 0.19% 124
2025
Q3
$787K Sell
5,466
-245
-4% -$30K 0.42% 67
2025
Q2
$575K Buy
5,711
+474
+9% +$36.2K 0.31% 91
2025
Q1
$401K Buy
5,237
+38
+0.7% +$2.91K 0.23% 117
2024
Q4
$359K Buy
5,199
+221
+4% +$15.9K 0.2% 120
2024
Q3
$363K Buy
+4,978
New +$367K 0.2% 113
2023
Q2
Sell
-3,320
Closed -$56.6K 243
2023
Q1
$56.6K Buy
+3,320
New +$64.5K 0.04% 185

Other funds holding INSM

Values First Advisors's INSM Position: Q1 2026 in Review

Values First Advisors increased its Insmed (INSM) stake by 7.1% in Q1 2026, buying an estimated $22.4K and bringing the position to 2,203 shares worth $360K. The position accounts for 0.19% of the portfolio, ranked #123.

Values First Advisors first reported a position in INSM in Q1 2023 and has held it in 8 quarters since. The position peaked at $787K in Q3 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Values First Advisors held 2,203 shares of Insmed worth $360K as of Q1 2026.
  • Values First Advisors bought 146 Insmed shares in Q1 2026, an estimated $22.4K.
  • Insmed made up 0.19% of Values First Advisors's portfolio in Q1 2026, its #123 holding.
  • Values First Advisors first reported a position in Insmed in Q1 2023 and has held it in 8 quarters since.
  • Values First Advisors's Insmed position peaked at $787K in Q3 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Values First Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.